News & blog

Keeping you up to date with the latest developments in science, policy and health
S1R1C1
 
BlogLong readsMonday September 6, 2021Some things are just too interesting to reduce to a few hundred words. The PHG Foundation's long read series takes a deeper dive into areas of new science and their implications for health policy
BlogWhat does ‘good governance’ look like for genome editing?Wednesday July 21, 2021PHG Policy Analyst, Tanya Brigden, usefully summarises the recommendations for the WHO's considerations towards genome editing
BlogExpanding the public and patient role in medical regulationTuesday July 6, 2021A recent consultation by the UK Medicines and Healthcare products Regulatory Agency (MHRA) indicates a welcome new direction for public and patient involvement (PPI).
BlogMaking the UK a science superpower – will policy moves pay off for health?Monday June 28, 2021The recent and abrupt change in Secretary of State for Health for the UK has overshadowed some very significant policy developments over the last week.
BlogCalls to review regulation of direct-to-consumer genetic testingTuesday June 22, 2021Excellent new report from Science and Technology Committee, which is gratifyingly in line with our own recommendations.
BlogPutting Genome UK into practice: genomic healthcare strategy implementationTuesday May 18, 2021Implementation plans for the UK’s landmark Genome UK strategy have been released, with specific commitments for all the major players in genomics research and healthcare revealed.
BlogBringing order to polygenic score reportingWednesday April 14, 2021Inconsistencies in the way polygenic score models are reported could delay their introduction into healthcare.
BlogGenomic surveillance in the roll out of vaccinesTuesday March 30, 2021Viral genome sequencing will be vital during vaccine roll out to ensure they are still effective in the face of ongoing genetic changes to the virus.
BlogA vision for the future of clinical researchFriday March 26, 2021Dr Philippa Brice dissects new UK government guidance on plans for the future of clinical research across the country.
S2R1C1